L

Lanthio Pharma

1 employees

Lanthio Pharma is focused on the research and development of therapeutic lantipeptide drugs for serious diseases.

Basic info

Industry

research services

Sectors

Biotechnology
lanthipeptides
critical care medicine
drug development
peptides
unmet medical need
Pharmaceutical
oncology
early development
drug discovery
receptor agonists
phage display
Therapeutics
GPCR
stabilized peptides

Date founded

2010

Funding rounds raised

Total raised

$6.2M

from 2 investors over 2 rounds

L

Lanthio Pharma raised $6.2M on November 28, 2012

Investors: Inkef and BGV (BioGeneration Ventures)

FAQ